141 related articles for article (PubMed ID: 25143180)
21. Treatment of malignant pheochromocytoma with combination chemotherapy.
Keiser HR; Goldstein DS; Wade JL; Douglas FL; Averbuch SD
Hypertension; 1985; 7(3 Pt 2):I18-24. PubMed ID: 3997232
[TBL] [Abstract][Full Text] [Related]
22. [Recurrent hypertensive crises and dyspnea following unilateral adrenalectomy in pheochromocytoma in a 44-year-old patient. Successful combination chemotherapy of malignant pheochromocytoma].
Saller B; Jacob K; Markl A; Zwiebel FM; Engelhardt D; Mann K
Internist (Berl); 1990 Jan; 31(1):78-81. PubMed ID: 2307558
[No Abstract] [Full Text] [Related]
23. [Malignant paraganglioma responsive to CVD therapy and radiation therapy : a case report].
Takezawa K; Kakimoto K; Yoshida T; Arai Y; Ono Y; Meguro N; Usami M
Hinyokika Kiyo; 2009 Nov; 55(11):691-4. PubMed ID: 19946186
[TBL] [Abstract][Full Text] [Related]
24. Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD), and human leukocyte interferon for metastatic uveal melanoma.
Pyrhönen S; Hahka-Kemppinen M; Muhonen T; Nikkanen V; Eskelin S; Summanen P; Tarkkanen A; Kivelä T
Cancer; 2002 Dec; 95(11):2366-72. PubMed ID: 12436444
[TBL] [Abstract][Full Text] [Related]
25. Sequential adjuvant therapy with doxorubicin/paclitaxel/cyclophosphamide for resectable breast cancer involving four or more axillary nodes.
Hudis CA; Seidman AD; Baselga J; Raptis G; Lebwohl D; Gilewski T; Currie V; Moynahan ME; Sklarin N; Fennelly D
Semin Oncol; 1995 Dec; 22(6 Suppl 15):18-23. PubMed ID: 8643965
[TBL] [Abstract][Full Text] [Related]
26. The CYVADIC regimen as a combination chemotherapy treatment option for advanced soft tissue sarcomas originating from the non-extremities.
Nakano K; Motoi N; Takahashi S
Intern Med; 2015; 54(2):187-93. PubMed ID: 25743010
[TBL] [Abstract][Full Text] [Related]
27. Three cases of malignant pheochromocytoma treated with cyclophosphamide, vincristine, and dacarbazine combination chemotherapy and alpha-methyl-p-tyrosine to control hypercatecholaminemia.
Tada K; Okuda Y; Yamashita K
Horm Res; 1998; 49(6):295-7. PubMed ID: 9623522
[TBL] [Abstract][Full Text] [Related]
28. Lomustine (chloroethylnitrosourea [CCNU]), ifosfamide, bleomycin, vincristine, and cisplatin (CIBO-P) is an effective regimen for patients with poor prognostic refractory or multiple disease recurrent aggressive non-Hodgkin lymphoma.
Musolino A; Perrone MA; Michiara M; Delnevo D; Franciosi V; Di Blasio B; Ceci G; Camisa R; Ardizzoni A; Cocconi G
Cancer; 2005 May; 103(10):2109-17. PubMed ID: 15803492
[TBL] [Abstract][Full Text] [Related]
29. Successful treatment of malignant pheochromocytoma with combination chemotherapy containing anthracycline.
Nakane M; Takahashi S; Sekine I; Fukui I; Koizumi M; Kage K; Ito Y; Aiba K; Horikoshi N; Hatake K; Ishikawa Y; Ogata E
Ann Oncol; 2003 Sep; 14(9):1449-51. PubMed ID: 12954587
[No Abstract] [Full Text] [Related]
30. [Case of malignant pheochromocytoma with successful control of systemic metastasis with CVD chemotherapy].
Minami T; Doi Y; Tetsuo H; Baba K; Seto S; Suzuki S; Hayano M; Yano S; Minami K; Oshibuchi E
Nihon Naika Gakkai Zasshi; 1996 Dec; 85(12):2078-80. PubMed ID: 9036176
[No Abstract] [Full Text] [Related]
31. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
32. A weekly alternating chemotherapy regimen with low toxicity for the treatment of aggressive lymphoma.
Bower M; Brock C; Gulliford T; O'Reilly SM; Smith DB; Newlands ES
Cancer Chemother Pharmacol; 1996; 38(1):106-9. PubMed ID: 8603443
[TBL] [Abstract][Full Text] [Related]
33. Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles.
Cunningham D; Hawkes EA; Jack A; Qian W; Smith P; Mouncey P; Pocock C; Ardeshna KM; Radford JA; McMillan A; Davies J; Turner D; Kruger A; Johnson P; Gambell J; Linch D
Lancet; 2013 May; 381(9880):1817-26. PubMed ID: 23615461
[TBL] [Abstract][Full Text] [Related]
34. Oral metronomic cyclophosphamide with and without methotrexate as palliative treatment for patients with metastatic breast carcinoma.
Gebbia V; Boussen H; Valerio MR
Anticancer Res; 2012 Feb; 32(2):529-36. PubMed ID: 22287742
[TBL] [Abstract][Full Text] [Related]
35. Malignant and benign pheochromocytoma: chromaffin granule transmitters and the response to medical and surgical treatment.
Rao F; Keiser HR; O'Connor DT
Ann N Y Acad Sci; 2002 Oct; 971():530-2. PubMed ID: 12438175
[No Abstract] [Full Text] [Related]
36. Treatment of advanced medullary thyroid carcinoma with a combination of cyclophosphamide, vincristine, and dacarbazine.
Wu LT; Averbuch SD; Ball DW; de Bustros A; Baylin SB; McGuire WP
Cancer; 1994 Jan; 73(2):432-6. PubMed ID: 8293411
[TBL] [Abstract][Full Text] [Related]
37. Promoter CpG island hypermethylation of the DNA repair enzyme MGMT predicts clinical response to dacarbazine in a phase II study for metastatic colorectal cancer.
Amatu A; Sartore-Bianchi A; Moutinho C; Belotti A; Bencardino K; Chirico G; Cassingena A; Rusconi F; Esposito A; Nichelatti M; Esteller M; Siena S
Clin Cancer Res; 2013 Apr; 19(8):2265-72. PubMed ID: 23422094
[TBL] [Abstract][Full Text] [Related]
38. Patterns of delivery of chemoimmunotherapy to patients with follicular lymphoma in the United States: results of the National LymphoCare Study.
Martin P; Byrtek M; Dawson K; Ziemiecki R; Friedberg JW; Cerhan JR; Flowers CR; Link BK
Cancer; 2013 Dec; 119(23):4129-36. PubMed ID: 24006156
[TBL] [Abstract][Full Text] [Related]
39. Treatment of malignant pheochromocytomas with 131-I metaiodobenzylguanidine and chemotherapy.
Sisson JC; Shapiro B; Shulkin BL; Urba S; Zempel S; Spaulding S
Am J Clin Oncol; 1999 Aug; 22(4):364-70. PubMed ID: 10440191
[TBL] [Abstract][Full Text] [Related]
40. Stage-adapted treatment of HIV-associated Hodgkin lymphoma: results of a prospective multicenter study.
Hentrich M; Berger M; Wyen C; Siehl J; Rockstroh JK; Müller M; Fätkenheuer G; Seidel E; Nickelsen M; Wolf T; Rieke A; Schürmann D; Schmidmaier R; Planker M; Alt J; Mosthaf F; Engert A; Arasteh K; Hoffmann C
J Clin Oncol; 2012 Nov; 30(33):4117-23. PubMed ID: 23045592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]